Avoid injecting through cuts, scrapes, irritated skin, or areas with rashes
As of July 2025, the FDA had received more than 1,100 reports of serious side effects and other health problems among patients taking compounded semaglutide and tirzepatide, including vomiting, diarrhea, abdominal pain and constipation
GLP-1 and GIP receptor agonists have a low intrinsic risk of causing hypoglycaemia when used alone, because their insulin-stimulating effects are glucose-dependent
Adding 2ml to a 5mg vial works but you'll inject the full vial for loading doses
doi: 10.7759/cureus.28160
Several studies which focus on blood biochemical markers, gut microbiota, and fecal SCFAs, uncover a close association between gut microbiota and the progression of MASLD, thereby improving its clinical diagnosis (142144)